Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
NBSE

Overview Financials Analysis Smart Money

NeuBase Therapeutics, Inc.

NBSE · NASDAQ

Analyze with AI

Filings1

Total reported value$51.5K

Manager	Shares	Value	Change
GREENLIGHT CAPITAL INC	136.4K	$51.5K	0.0%

SymbolNBSE

Market Cap$1.4M

IPO Date2004-05-28

CEOTodd P. Branning

Employees37

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Vision Marine Technologies Inc.

VMAR

$0.976

+156.77%

Shineco, Inc.

SISI

$0.375

+67.41%

B. Riley Financial, Inc.

RILY

$5.72

+53.76%

Cementos Pacasmayo S.A.A.

CPAC

$10.64

+52.22%

Everbright Digital Holding Limited Ordinary Shares

EDHL

$0.5472

+43.40%

Peers

Oncternal Therapeutics, Inc.

ONCT · NASDAQ

$0.5266

-24.12%

OncoSec Medical Incorporated

ONCSQ · OTC

$0.0001

+0.00%

Cassava Sciences, Inc. Warrant

SAVAW · NASDAQ

$0.03

+0.00%

ASLAN Pharmaceuticals Limited

ASLN · NASDAQ

$0.60

-14.27%

VBI Vaccines Inc.

VBIV · NASDAQ

$0.0653

-50.87%

CohBar, Inc.

CWBR · NASDAQ

$0.41

+0.00%

Timber Pharmaceuticals, Inc.

TMBR · AMEX

$0.3426

+0.74%

9 Meters Biopharma, Inc.

NMTRQ · OTC

$0.0001

+0.00%

Impel Pharmaceuticals Inc.

IMPL · NASDAQ

$0.04

-27.27%

Altamira Therapeutics Ltd.

CYTO · NASDAQ

$0.30

+100.00%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.